Cancer Immunology, Immunotherapy (2022) 71:2703–2715 https://doi.org/10.1007/s00262-022-03184-7 ORIGINAL ARTICLE Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma Yoshitaka Narita1 · Yoshiko Okita2,3 · Yoshiki Arakawa4 ...
However, data on HIV testing, PrEP use, and PrEP knowledge among trans and non-binary people are limited. We analysed data from the ‘Sexuelle Gesundheit in trans und nicht-binären Communitys’ (TASG) study, a participatory study on HIV/STI and sexual health among trans and non-binary ...